Biotech

All Articles

Analysts dig into Avidity's DMD gain, uncovering subtleties in data

.Avidity Biosciences satisfied capitalists along with stage 1/2 records in Duchenne muscular dystrop...

Actinogen's cortisol blocker stops working phase 2 clinical depression research study

.Actinogen Medical's cortisol blocker has actually overlooked the primary endpoint of a phase 2 rese...

Bivictrix determines going private only method to take ADC in to medical clinic

.Antibody-drug conjugates (ADCs) have actually been at the center of numerous a billion-dollar biobu...

TPG tops up funds to $580M for investments around lifestyle sciences

.Possession supervisor TPG, which has assisted biotechs including Sionna Therapies as well as Santa ...

Merck ceases period 3 TIGIT test in lung cancer for impossibility

.Merck &amp Co.'s TIGIT course has actually endured yet another obstacle. Months after shuttering a ...

After a hard year, Exscientia folds up into Recursion

.After a year defined by pipe cuts, the variation of its own CEO as well as cutbacks, Exscientia wil...

Cullinan, after $25M bargain, hands back bispecific to Port

.Cullinan Therapy was made an impression on good enough with Harbour BioMed's bispecific immune syst...

A more detailed look at Ferocious Biotech's Fierce 15

.Within this full week's episode of "The Top Pipe," our team're diving into Strong Biotech's yearly ...

Lilly deals with stage 2 failing of tau-targeting med

.The confetti is still soaring from Eli Lilly's celebration commemorating the approval of Alzheimer'...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of significant management hirings, firings an...